| Jonna Coxon Goulding, MD | |
|
130 Fisher Rd, Berlin, VT 05602-9516 | |
| (802) 225-3994 | |
| (802) 371-5985 |
| Full Name | Jonna Coxon Goulding |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 31 Years |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962415042 | NPI | - | NPPES |
| OVN1426 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0420009355 (Vermont) | Secondary |
| 207QH0002X | Family Medicine - Hospice And Palliative Medicine | 042.0009355 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
When it comes to delivering drugs, nanoparticles shaped like rods and worms are the best bet for making the daunting journey to the centre of a cell, new Australian research suggests.
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.
Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2009. The Company reported third quarter net sales of $976 million, an increase of 2.4% reported and 3.6% constant currency over the third quarter of 2008. Diluted earnings per share for the quarter were $0.70 reported and $0.88 adjusted, a decrease of 9.3% adjusted from the prior year period.
› Verified 1 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
When it comes to delivering drugs, nanoparticles shaped like rods and worms are the best bet for making the daunting journey to the centre of a cell, new Australian research suggests.
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.
Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2009. The Company reported third quarter net sales of $976 million, an increase of 2.4% reported and 3.6% constant currency over the third quarter of 2008. Diluted earnings per share for the quarter were $0.70 reported and $0.88 adjusted, a decrease of 9.3% adjusted from the prior year period.
› Verified 1 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
When it comes to delivering drugs, nanoparticles shaped like rods and worms are the best bet for making the daunting journey to the centre of a cell, new Australian research suggests.
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.
Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2009. The Company reported third quarter net sales of $976 million, an increase of 2.4% reported and 3.6% constant currency over the third quarter of 2008. Diluted earnings per share for the quarter were $0.70 reported and $0.88 adjusted, a decrease of 9.3% adjusted from the prior year period.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonna Coxon Goulding, MD Po Box 547, Att: Cvmc Finance Dept, Barre, VT 05641-0547 Ph: (802) 225-3994 | Jonna Coxon Goulding, MD 130 Fisher Rd, Berlin, VT 05602-9516 Ph: (802) 225-3994 |
News Archive
When it comes to delivering drugs, nanoparticles shaped like rods and worms are the best bet for making the daunting journey to the centre of a cell, new Australian research suggests.
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.
Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2009. The Company reported third quarter net sales of $976 million, an increase of 2.4% reported and 3.6% constant currency over the third quarter of 2008. Diluted earnings per share for the quarter were $0.70 reported and $0.88 adjusted, a decrease of 9.3% adjusted from the prior year period.
› Verified 1 days ago
Dr. Jennifer Brennan Bamford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd., Uvm Medical Center - Fm/berlin, Berlin, VT 05602 Phone: 802-847-7000 Fax: 802-847-7103 | |
Dr. Benjamin Arthur Flinn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd Unit 1, Berlin, VT 05602 Phone: 802-225-7000 | |
Thomas James Curchin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 Granger Rd, Suite 2, Berlin, VT 05602 Phone: 802-225-5810 Fax: 802-371-4821 | |
Dr. Stuart E Williams, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Dr. Jose Lopez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3-1, Berlin, VT 05602 Phone: 802-225-9000 | |
Dr. Lise S Kowalski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd, Suite 3-1, Berlin, VT 05602 Phone: 802-225-7000 | |
Arturo Guajardo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Unit 1, Berlin, VT 05602 Phone: 802-225-7103 |